Kenneth Bilchick, MD, a UVA Health heart rhythm specialist who co-led the study along with Tiago Palmisano, MD, and David Guarraia, MD, explained, The survival curves in all three groups indicated that there was a reduction in the risk of incident atrial fibrillation regardless of whether you gained weight, lost a little weight, or lost a lot of weight. Among the medicines studied, semaglutide showed the strongest association with reduced Afib risk
Stopping medication once you reach your goal weight might sound appealing, but it often results in weight regain
Emerging research involving tripeptides as anticancer agents has explored alternative strategies to improve survival rates in cancer patients worldwide
In aqueous solution, peptides are vulnerable to hydrolysis, oxidation, and aggregation over time